Reversible weight gain and prolactin levels - Long-term follow-up in childhood

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 9, 2005, Pages 921-924

  Galluzzi, Fiorella ^a   Salti, R ^a   Stagi, S ^a   La Cauza, F ^a   Chiarelli, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Amenorrhea; BMI; Hyperprolactinaemia; Obesity; Overweight; Prolactin; Prolactinoma

Indexed keywords

FOLLITROPIN; GADOLINIUM; GONADORELIN; LUTEINIZING HORMONE; PERGOLIDE; PROLACTIN;

APGAR SCORE; ARTICLE; BODY MASS; BONE AGE; CALORIC INTAKE; CASE REPORT; CHILD; DISEASE ASSOCIATION; DOSE RESPONSE; ECHOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HORMONAL REGULATION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; INSULIN BLOOD LEVEL; LONG TERM CARE; MENARCHE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PROLACTIN BLOOD LEVEL; WEIGHT GAIN;

EID: 27844457040     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.9.921     Document Type: Article

References (17)

1. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998; 19: 225-268.
2. Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P. Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 2001; 142: 532-537.
3. Delgrange E, Donckier J, Maiter D. Hyperprolactinemia, as a reversible cause of weight gain in male patients? Clin Endocrinol (Oxf) 1999; 50: 271.
4. Greenman Y, Tordjman K, Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 1998; 48: 547-553.
5. Yermus R, Ezzat S. Does normalization of prolactin levels result in weight loss in patients with prolactin secreting pituitary adenomas? Clin Endocrinol (Oxf) 2002; 56: 562.
6. Ferreira MF, Sobrinho LG, Pires JS, Silva ME, Santos MA, Sousa MF. Endocrine and psychological evaluation of women with recent weight gain. Psychoneuroendocrinology 1995; 20: 53-63.
7. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am 2003; 32: 895-914.
8. Rojdmark S, Rossner S. Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting. Metabolism 1991; 40:191-195.
9. Weaver JU, Noonan K, Kopelman PG. An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity. Clin Endocrinol (Oxf) 1991; 35: 97-102.
10. Muldoon MF, Mackey RH, Williams KV, Korytkowski MT, Flory JD, Manuck SB. Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity. J Clin Endocrinol Metab 2004; 89: 266-271.
11. Wang DY, De Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Verstraeten AA, Moore JW, Fentiman IS, Chaudary M, Hayward JL, Gravelle IH. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. Eur J Cancer Clin Oncol 1987; 23: 1541-1548.
12. Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H. Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab 2004; 89: 4445-4449.
13. Papaleo E, Doldi N, De Santis L, Marelli G, Marsiglio E, Rofena S, Ferrari A. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod 2001; 16: 2263-2266.
14. Bahceci M, Tuzcu A, Bahceci S, Tuzcu S. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome? J Endocrinol Invest 2003; 26: 655-659.
15. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popovic V. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 2002; 147: 77-84.
16. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671.
17. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS. Brain dopamine and obesity. Lancet 2001; 357: 354-357.